BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 18617775)

  • 1. Gastro-oesophageal reflux disease and irritable bowel syndrome: a significant association in an Iranian population.
    Solhpour A; Pourhoseingholi MA; Soltani F; Zarghi A; Solhpour A; Habibi M; Zali MR
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):719-25. PubMed ID: 18617775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive association between gastro-oesophageal reflux disease and irritable bowel syndrome in a Chinese population.
    Cheung TK; Lam KF; Hu WH; Lam CL; Wong WM; Hui WM; Lai KC; Lam SK; Wong BC
    Aliment Pharmacol Ther; 2007 May; 25(9):1099-104. PubMed ID: 17439511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overlap of gastro-oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population.
    Jung HK; Halder S; McNally M; Locke GR; Schleck CD; Zinsmeister AR; Talley NJ
    Aliment Pharmacol Ther; 2007 Aug; 26(3):453-61. PubMed ID: 17635380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between respiratory symptoms, lung function and gastro-oesophageal reflux symptoms in a population-based birth cohort.
    Hancox RJ; Poulton R; Taylor DR; Greene JM; McLachlan CR; Cowan JO; Flannery EM; Herbison GP; Sears MR; Talley NJ
    Respir Res; 2006 Dec; 7(1):142. PubMed ID: 17147826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for gastro-oesophageal reflux disease symptoms: a community study.
    Mohammed I; Nightingale P; Trudgill NJ
    Aliment Pharmacol Ther; 2005 Apr; 21(7):821-7. PubMed ID: 15801917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irritable bowel, smoking and oesophageal acid exposure: an insight into the nature of symptoms of gastro-oesophageal reflux.
    Zimmerman J
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1297-303. PubMed ID: 15606391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irritable bowel syndrome, gastro-oesophageal reflux disease and dyspepsia: overlap analysis using loglinear models.
    Pourhoseingholi A; Vahedi M; Pourhoseingholi MA; Ashtari S; Moghimi-Dehkordi B; Safaee A; Zali MR
    Arab J Gastroenterol; 2012 Mar; 13(1):20-3. PubMed ID: 22560820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of reflux oesophagitis among upper endoscopies of Iranian patients.
    Rezailashkajani M; Roshandel D; Shafaee S; Zali MR
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):499-506. PubMed ID: 17489061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastro-oesophageal reflux disease and irritable bowel syndrome significantly associated with metabolic syndrome.
    Cholongitas E; Pipili C; Dasenaki M
    Scand J Gastroenterol; 2008; 43(11):1405-6. PubMed ID: 18752148
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study.
    Lee SY; Lee KJ; Kim SJ; Cho SW
    Digestion; 2009; 79(3):196-201. PubMed ID: 19342860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, clinical spectrum and atypical symptoms of gastro-oesophageal reflux in Argentina: a nationwide population-based study.
    Chiocca JC; Olmos JA; Salis GB; Soifer LO; Higa R; Marcolongo M;
    Aliment Pharmacol Ther; 2005 Aug; 22(4):331-42. PubMed ID: 16098000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct clinical characteristics between patients with nonerosive reflux disease and those with reflux esophagitis.
    Wu JC; Cheung CM; Wong VW; Sung JJ
    Clin Gastroenterol Hepatol; 2007 Jun; 5(6):690-5. PubMed ID: 17481961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cost analysis of gastro-oesophageal reflux disease and dyspepsia in Iran.
    Rezailashkajani M; Roshandel D; Shafaee S; Zali MR
    Dig Liver Dis; 2008 Jun; 40(6):412-7. PubMed ID: 18342588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hygiene could affect GERD prevalence independently: a population-based study in Tehran.
    Nouraie M; Radmard AR; Zaer-Rezaii H; Razjouyan H; Nasseri-Moghaddam S; Malekzadeh R
    Am J Gastroenterol; 2007 Jul; 102(7):1353-60. PubMed ID: 17437507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Asan-si, Korea.
    Cho YS; Choi MG; Jeong JJ; Chung WC; Lee IS; Kim SW; Han SW; Choi KY; Chung IS
    Am J Gastroenterol; 2005 Apr; 100(4):747-53. PubMed ID: 15784014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of gastro-oesophageal reflux disease in Spain and associated factors.
    Ponce J; Vegazo O; Beltrán B; Jiménez J; Zapardiel J; Calle D; Piqué JM;
    Aliment Pharmacol Ther; 2006 Jan; 23(1):175-84. PubMed ID: 16393295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Onset and disappearance of reflux symptoms in a Chinese population: a 1-year follow-up study.
    Wong WM; Lai KC; Lam KF; Hui WM; Huang JQ; Xia HH; Hu WH; Lam CL; Chan CK; Lam SK; Wong BC
    Aliment Pharmacol Ther; 2004 Oct; 20(7):803-12. PubMed ID: 15379841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uninvestigated dyspepsia and its related factors in an Iranian community.
    Barzkar M; Pourhoseingholi MA; Habibi M; Moghimi-Dehkordi B; Safaee A; Pourhoseingholi A; Khalafii A; Zali MR
    Saudi Med J; 2009 Mar; 30(3):397-402. PubMed ID: 19271070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of gastroesophageal reflux disease in Tehran, Iran.
    Ehsani MJ; Maleki I; Mohammadzadeh F; Mashayekh A
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1419-22. PubMed ID: 17716346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative reappraisal of the Rome II and Rome III diagnostic criteria: are we getting closer to the 'true' prevalence of irritable bowel syndrome?
    Sperber AD; Shvartzman P; Friger M; Fich A
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):441-7. PubMed ID: 17489053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.